Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARROW: Standard versus Pre-emptive Antibiotic Treatment after Whipple’s Procedure
2024-510766-16-00Phase 4Authorised
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cefuroxime and metronidazole in surgical site infection (SSI), Organ/Space Surgical Site Infection, pancreatic fistula (POPF) and 7 more (2 arms), sponsored by Leiden University Medical Center. Planned start Jun 2024; status: authorised.
02
Drugs
cefuroximemetronidazole
03
Conditions
surgical site infection (SSI)Organ/Space Surgical Site Infectionpancreatic fistula (POPF)Bile leakEnteric leak
Beyond the preview
Go deeper on 2024-510766-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510766-16-00.